Abstract: Disclosed herein is a biodegradable and bioactive glass-ceramic fabricated by mixing a slowly biodegradable glass-ceramic and a highly biodegradable glass-ceramic in a predetermined mixing ratio wherein the bioactivity is maintained to be constant, and the biodegradation rate is controlled by the mixing ratio. The biodegradable and bioactive glass-ceramic is fabricated from a composition consisting of calcium oxide (CaO), silica (SiO2), boron oxide (B2O3), magnesium oxide (MgO), calcium fluoride (CaF2) and phosphorus pentoxide (P2O5).

Abstract: Disclosed is a method for producing a transparent and homogenized polymeric sol of a calcium phosphate compound, containing apatite and having excellent wettability and bioactivity, according to a sol-gel synthesis, and a method for coating the polymeric sol on a metal implant, in which the polymeric sol is coated on the metal implant and then heat-treated to form a dense coated layer strongly bonded to the metal implant. The polymeric sol is obtained by process of preparing a calcium salt solution, containing calcium ethoxide dissolved in organic acid, and a phosphate solution, containing triethyl phosphite or triethyl phosphate dissolved in the organic acid, mixing the calcium salt solution with the phosphate solution to produce a mixed solution, and aging the mixed solution.

Abstract: Disclosed herein are a self-foamed porous ceramic composition and a method for making a porous ceramic using the self-foamed porous ceramic composition. The self-foamed porous ceramic is obtained by fabricating a glass consisting of 41˜47 mole % of calcium oxide (CaO), 41˜47 mole % of silica (SiO2) and 6˜18 mole % of borate (B2O3), pulverizing the glass into a finely-divided glass powder having an average particle size of 1˜10 ?m, molding the glass powder, and sintering the molded glass powder.

Abstract: A bone graft substitute using magnesium substituted calcium phosphate compounds and a method of manufacturing the same is provided in which the bone graft substitute is used for recovering bones damaged due to a bone fracture. The method of manufacturing a bone graft substitute includes the steps of mixing powdered calcium pyrophosphate and a magnesium included compound to thereby obtain a composition, pressure-forming the compositions to obtain a plastic body; and sintering the plastic body.

Abstract: Disclosed herein are a self-foamed porous ceramic composition and a method for making a porous ceramic using the self-foamed porous ceramic composition. The self-foamed porous ceramic is obtained by fabricating a glass consisting of 41˜47 mole % of calcium oxide (CaO), 41˜47 mole % of silica (SiO2) and 6˜18 mole % of borate (B2O3), pulverizing the glass into a finely-divided glass powder having an average particle size of 1˜10 &mgr;m, molding the glass powder, and sintering the molded glass powder.

Abstract: Disclosed herein is a biodegradable and bioactive glass-ceramic fabricated by mixing a slowly biodegradable glass-ceramic and a highly biodegradable glass-ceramic in a predetermined mixing ratio wherein the bioactivity is maintained to be constant, and the biodegradation rate is controlled by the mixing ratio. The biodegradable and bioactive glass-ceramic is fabricated from a composition consisting of calcium oxide (CaO), silica (SiO2), boron oxide (B2O3), magnesium oxide (MgO), calcium fluoride (CaF2) and phosphorus pentoxide (P2O5).

Abstract: A bioactive biphasic ceramic composition combining apatite and wollastonite is disclosed, in order to solve the defect of apatite ceramic that has poor bioactivity though it is excellent in biocompatibility, which has improved bioactivity, as compared to monophasic ceramics of apatite or wollastonite. The ceramic composition is produced by steps of: providing a composition including powders of apatite of formula Ca10(PO4)6X, in which X is any one of O, (OH)2, CO3, F2 and Cl2, and wollastonite (CaSiO3) in a weight ratio of 5:95 to 90:10, forming the composition into a desired body by press or forming the composition into a porous body, and sintering the formed body.

Abstract: A bone graft substitute using magnesium substituted calcium phosphate compounds and a method of manufacturing the same is provided in which the bone graft substitute is used for recovering bones damaged due to a bone fracture. The method of manufacturing a bone graft substitute includes the steps of mixing powdered calcium pyrophosphate and a magnesium included compound to thereby obtain a composition, pressure-forming the compositions to obtain a plastic body; and sintering the plastic body.